Table 4. Rates for warfarin use at discharge in patients with heart failure and atrial fibrillation.
| Country | Unadjusted Rate (%) |
Risk-Adjusted Rate* (%) |
OR (95% CI) |
P Value |
|---|---|---|---|---|
| Mexico | 60.0 | 48.6 | 2.34 (1.2–4.59) | 0.0132 |
| Australia | 59.4 | 65.2 | 3.74 (2.24–6.27) | <0.0001 |
| Hong Kong | 43.0 | 52.5 | 1.99 (1.28–3.10) | <0.0021 |
| Indonesia | 36.2 | 34.3 | 0.88 (0.37–2.06) | 0.76 |
| Malaysia | 50.8 | 52.9 | 2.08 (1.31–3.30) | 0.0018 |
| Philippines | 30.3 | 25.5 | 0.52 (0.33–0.84) | <0.0076 |
| Singapore | 30.2 | 35.8 | 1.01 (0.64–1.59) | 0.96 |
| Taiwan | 18.3 | 25.1 | 0.62 (0.36–1.04) | 0.0721 |
| Thailand | 49.4 | 49.4 | 1.93 (1.18–3.15) | 0.0086 |
| Brazil | 34.4 | 37.5 | Reference | -- |
Adjusted for age, coronary artery disease, pacemaker, and creatinine levels.
CI indicates confidence interval; OR, odds ratio.